240 related articles for article (PubMed ID: 19651782)
1. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
Cushman I; Casey PJ
J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
[TBL] [Abstract][Full Text] [Related]
2. RHO methylation matters: a role for isoprenylcysteine carboxylmethyltransferase in cell migration and adhesion.
Cushman I; Casey PJ
Cell Adh Migr; 2011; 5(1):11-5. PubMed ID: 20798596
[TBL] [Abstract][Full Text] [Related]
3. Isoprenylcysteine carboxyl methyltransferase modulates endothelial monolayer permeability: involvement of RhoA carboxyl methylation.
Lu Q; Harrington EO; Hai CM; Newton J; Garber M; Hirase T; Rounds S
Circ Res; 2004 Feb; 94(3):306-15. PubMed ID: 14699010
[TBL] [Abstract][Full Text] [Related]
4. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha stimulation of Rac1 activity. Role of isoprenylcysteine carboxylmethyltransferase.
Papaharalambus C; Sajjad W; Syed A; Zhang C; Bergo MO; Alexander RW; Ahmad M
J Biol Chem; 2005 May; 280(19):18790-6. PubMed ID: 15647276
[TBL] [Abstract][Full Text] [Related]
6. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
[TBL] [Abstract][Full Text] [Related]
7. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
[TBL] [Abstract][Full Text] [Related]
8. Diacylglycerol kinase zeta regulates actin cytoskeleton reorganization through dissociation of Rac1 from RhoGDI.
Abramovici H; Mojtabaie P; Parks RJ; Zhong XP; Koretzky GA; Topham MK; Gee SH
Mol Biol Cell; 2009 Apr; 20(7):2049-59. PubMed ID: 19211846
[TBL] [Abstract][Full Text] [Related]
9. Control of RhoA methylation by carboxylesterase I.
Cushman I; Cushman SM; Potter PM; Casey PJ
J Biol Chem; 2013 Jun; 288(26):19177-83. PubMed ID: 23658012
[TBL] [Abstract][Full Text] [Related]
10. MLL regulates the actin cytoskeleton and cell migration by stabilising Rho GTPases via the expression of RhoGDI1.
Chinchole A; Lone KA; Tyagi S
J Cell Sci; 2022 Oct; 135(20):. PubMed ID: 36111497
[TBL] [Abstract][Full Text] [Related]
11. RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration.
Rolli-Derkinderen M; Toumaniantz G; Pacaud P; Loirand G
Mol Cell Biol; 2010 Oct; 30(20):4786-96. PubMed ID: 20696841
[TBL] [Abstract][Full Text] [Related]
12. An activating mutant of Rac1 that fails to interact with Rho GDP-dissociation inhibitor stimulates membrane ruffling in mammalian cells.
Gandhi PN; Gibson RM; Tong X; Miyoshi J; Takai Y; Konieczkowski M; Sedor JR; Wilson-Delfosse AL
Biochem J; 2004 Mar; 378(Pt 2):409-19. PubMed ID: 14629200
[TBL] [Abstract][Full Text] [Related]
13. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
[TBL] [Abstract][Full Text] [Related]
14. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation.
Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L
Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868
[TBL] [Abstract][Full Text] [Related]
15. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.
Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ
J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
Zhu Y; Casey PJ; Kumar AP; Pervaiz S
Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
Pan Q; Liu R; Banu H; Ma L; Li H
Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
[TBL] [Abstract][Full Text] [Related]
18. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
19. Disruption of RhoGDI and RhoA regulation by a Rac1 specificity switch mutant.
Wong KW; Mohammadi S; Isberg RR
J Biol Chem; 2006 Dec; 281(52):40379-88. PubMed ID: 17074770
[TBL] [Abstract][Full Text] [Related]
20. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
Chai TF; Manu KA; Casey PJ; Wang M
Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
